Dixon's Wellness Frontier: A Spa Bets Big on High-Tech Healing

DIXON, IL – June 15, 2026 – In a move that signals a broader shift in the American healthcare landscape, a medical spa in northwestern Illinois is making a significant capital investment in technologies that promise to sculpt bodies, restore bladder control, and treat depression—all without a single incision. The Wellspring Medical Spa, led by nurse practitioner Jordanna Devine, is positioning itself as a regional pioneer, bringing a suite of advanced, non-invasive devices to a market far from the traditional hubs of cosmetic and wellness innovation.

On July 8, the spa will host a “Medical Wellness Retreat,” offering live demonstrations of three key technologies: Emsculpt NEO for body contouring, EMSELLA for incontinence, and EXOMIND for depression. While press releases often paint a simple picture of progress, the story here is more complex. It's a tale of entrepreneurial vision, the powerful economics of the wellness industry, and a critical look at the technology driving a revolution in patient care, where consumer demand for quick, effective solutions is reshaping business models from the ground up.

A New Arsenal for Body and Mind

At the heart of The Wellspring Medical Spa's new offering are three distinct but philosophically aligned devices that leverage electromagnetic energy and other forces to stimulate the body's own processes. The appeal is clear: significant results with minimal downtime.

First is Emsculpt NEO, a body-sculpting device that has gained considerable media attention. It combines two technologies simultaneously: radiofrequency (RF) heating to permanently destroy fat cells and high-intensity focused electromagnetic (HIFEM) energy to induce powerful muscle contractions. The company claims a single 30-minute session is equivalent to performing 20,000 crunches. The device is FDA-cleared for fat reduction and muscle building, tapping directly into a consumer base seeking to tone stubborn areas that resist diet and exercise.

Next is the EMSELLA chair, which targets a widespread but often undiscussed medical issue: urinary incontinence. Patients sit fully clothed on the chair for about 28 minutes as HIFEM technology stimulates deep pelvic floor muscles, delivering the equivalent of 11,000 Kegel exercises. With a reported 98% patient satisfaction rate and FDA clearance for treating incontinence, it offers a dignified, non-surgical alternative. However, it's crucial to contextualize its efficacy. While studies show significant quality-of-life improvements, comparative data suggests that while superior to pelvic floor muscle training alone, its one-year recurrence rate (31%) is higher than that of corrective surgery (14%). It represents a trade-off: less risk and no downtime for potentially less durable results.

Perhaps the most intriguing technology is EXOMIND, a non-invasive brain stimulation device for treating depression. It uses a form of Transcranial Magnetic Stimulation (TMS) to apply gentle magnetic pulses to the head, targeting brain regions involved in mood regulation, such as the left dorsolateral prefrontal cortex. The goal is to enhance neuroplasticity and improve neural communication. It's vital to understand its regulatory status. EXOMIND is FDA-cleared, not FDA-approved. This distinction is critical; “clearance” means the device is substantially equivalent to another legally marketed device, whereas “approval” requires rigorous clinical trials to demonstrate safety and effectiveness for a specific use. While traditional TMS has been cleared for depression since 2008 and is well-studied, newer applications like EXOMIND are part of an evolving field. The spa reports users experience improved sleep, energy, and concentration, aligning with the broader trend of integrating mental wellness into a holistic health model.

The Strategic Bet on Regional Wellness

The decision to bring this trifecta of high-tech equipment to Dixon, Illinois, is a calculated business strategy. It reflects both the personal vision of its founder and powerful macroeconomic trends. Jordanna Devine, a family nurse practitioner with a background in emergency and urgent care, represents a new class of healthcare entrepreneur. Her transition from acute care to wellness-based practice is a story playing out across the country.

“I believe my patients deserve the latest treatments that help them look and feel their best,” Devine stated in the official announcement. “We are happy to be the only center in the area that provides cutting edge, noninvasive health and wellness devices.”

This move taps into the explosive growth of the non-invasive aesthetic treatment market, which analysts project could exceed $100 billion globally by 2035. The driving forces are an aging population, a cultural shift towards preventative self-care, and a strong consumer preference for procedures that deliver results without the risks and recovery time of surgery. By bundling body sculpting, pelvic health, and mental wellness, The Wellspring Medical Spa is creating a one-stop shop that addresses the interconnectedness of physical and emotional well-being—a key trend in the modern medical spa industry.

Establishing such a center in a regional community is a strategic gamble. It challenges the assumption that cutting-edge care is exclusive to major metropolitan areas. If successful, it carves out a defensible niche as a regional leader, drawing clients from a wide radius who might otherwise not have access to these treatments. The spa’s claim to be “among the first” in northwestern Illinois is a powerful marketing tool, positioning it as an innovator rather than a follower.

The Patient's Bottom Line: Decoding Cost and Commitment

For the consumer, the allure of these technologies is tempered by their cost. As these are largely considered aesthetic or wellness procedures, they are rarely covered by insurance. A full series of Emsculpt NEO treatments can run between $3,000 and $6,000. An initial course of six EMSELLA sessions typically costs $1,800 to $3,000. A series of EXOMIND treatments for depression is similarly priced, often starting around $3,000. While some insurers are beginning to cover TMS for treatment-resistant depression, coverage for newer devices can be inconsistent.

This places the financial burden squarely on the patient, transforming these treatments from simple medical procedures into significant discretionary investments. The spa’s event promotion—$500 off a package—is a classic strategy to lower the barrier to entry for these high-ticket services. Furthermore, the results are not always permanent. Both Emsculpt NEO and EMSELLA often require periodic maintenance sessions to sustain their effects, creating an ongoing financial commitment for the patient and a recurring revenue stream for the business.

This model highlights a fundamental shift in healthcare delivery. It is increasingly consumer-driven, marketed directly to patients who are willing to pay out-of-pocket for improvements in their quality of life, whether it’s a more sculpted abdomen, freedom from incontinence, or relief from depressive symptoms. The success of ventures like The Wellspring Medical Spa will ultimately depend on their ability to manage patient expectations, deliver tangible results, and prove that the investment in high-tech wellness provides a return that clients can both see and feel.